Skip to search formSkip to main contentSkip to account menu

Dynacirc

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Isradipine

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Harmony and heresy of an L-type calcium channel inhibitor: suppression of cocaine seeking via increased dopamine transmission in the nucleus accumbens
2013
2013
Improvement of photostability and dissolution profile of isradipine using inclusion complex
Inclusion complexes using β-cyclodextrin were manufactured by solvent evaporation method. Then, sustained release (SR… 
1998
1998
Determination of degradation products from the calcium-channel blocker isradipine.
1994
1994
Effect of isradipine in black patients with very severe hypertension. 24-hour ambulatory blood pressure monitoring and echocardiographic evaluation.
Fifty consecutive black patients with very severe hypertension (sitting diastolic blood pressure > or = 120 mm Hg and systolic… 
1991
1991
Isradipine in the treatment of mild to moderate essential hypertension.
Male patients with supine diastolic blood pressures above 95 mmHg after placebo therapy received twice daily isradipine (Dynacirc… 
1991
1991
TREATMENT OF ESSENTIAL HYPERTENTION A PRELIMINARY CLINICAL OBSERVATION
Dynacirc (Isradipine)is a new dihydropyride derived calcium antagonist,15 ess- ential hypertensive cases (male 5 female 10) were… 
Review
1990
Review
1990
Isradipine in the treatment of hypertension: a clinical profile.
Isradipine (DynaCirc, PK 200-110) is a new calcium channel blocker of the dihydropyridine class. In controlled, double-blind… 
1988
1988
Clinical pharmacokinetics of isradipine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)